Bausch Health Cos Total Liabilities 2010-2024 | BHC

Bausch Health Cos total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Bausch Health Cos Annual Total Liabilities
(Millions of US $)
2023 $27,432
2022 $25,426
2021 $29,236
2020 $30,594
2019 $32,727
2018 $29,677
2017 $31,553
2016 $40,271
2015 $42,936
2014 $20,903
2013 $22,738
2012 $14,233
2011 $9,178
2010 $5,884
2009 $705
Bausch Health Cos Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $26,782
2024-06-30 $26,722
2024-03-31 $27,087
2023-12-31 $27,432
2023-09-30 $27,299
2023-06-30 $25,232
2023-03-31 $25,300
2022-12-31 $25,426
2022-09-30 $25,865
2022-06-30 $27,918
2022-03-31 $29,231
2021-12-31 $29,236
2021-09-30 $29,387
2021-06-30 $30,653
2021-03-31 $30,321
2020-12-31 $30,594
2020-09-30 $30,907
2020-06-30 $30,850
2020-03-31 $31,075
2019-12-31 $32,727
2019-09-30 $29,107
2019-06-30 $29,666
2019-03-31 $29,772
2018-12-31 $29,677
2018-09-30 $30,540
2018-06-30 $30,890
2018-03-31 $31,275
2017-12-31 $31,553
2017-09-30 $34,552
2017-06-30 $37,704
2017-03-31 $38,339
2016-12-31 $40,271
2016-09-30 $41,488
2016-06-30 $42,259
2016-03-31 $43,244
2015-12-31 $42,936
2015-09-30 $41,990
2015-06-30 $41,785
2015-03-31 $31,991
2014-12-31 $20,903
2014-09-30 $21,826
2014-06-30 $22,528
2014-03-31 $22,786
2013-12-31 $22,738
2013-09-30 $23,143
2013-06-30 $14,080
2013-03-31 $13,899
2012-12-31 $14,233
2012-09-30 $10,361
2012-06-30 $10,324
2012-03-31 $9,543
2011-12-31 $9,178
2011-09-30 $7,804
2011-06-30 $7,162
2011-03-31 $6,979
2010-12-31 $5,884
2010-09-30 $5,786
2010-06-30 $669
2010-03-31 $661
2009-12-31 $705
2009-09-30 $731
2009-06-30 $804
2009-03-31 $380
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00